Sixty two medicinal products from the list of vital and essential drugs (VED) were launched onto the Russian market over the five past years. This was announced by Sergey Tsyb, the Deputy Minister of Industry and Trade of Russia, at the Second GMP Conference held in Gelendzhik.
Eighteen medicines from the list of vital and essential drugs were registered in H1 2017. Another 10 drugs are expected to be launched within the second half of this year.
Currently, the share of Russian-made medicines in the VED list is 83.3%. The Deputy Minister specifically noted that the share of packaging in the Russian Federation is declining. In Q1 2017, it was 6% in physical terms and 15% in monetary terms.
“This shows that the companies are actively moving to deeper localization,” said Sergey Tsyb.